Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Tdf Hiv'
Tdf Hiv published presentations and documents on DocSlides.
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
by luanne-stotts
Progressive rises in weight and clinical obesity ...
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
by tawny-fly
M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
by dorothy
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
by zane419
Study 105. Atazanavir + [Cobicistat or Ritonavir] ...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
by kylo
Andrew Hill, Francois Venter, Eric . Delaporte. , ...
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
by ramon803
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
by keanu817
RADAR Trial. Raltegravir. + Darunavir/r versus TD...
Schéma
by tatiana-dople
de . l’étude. Critère. principal . –. pu...
1 Adam O’Neill Leonid
by celsa-spraggs
Reyzin. Boston University. . A Unified Approach ...
HBV resistance and
by calandra-battersby
immune escape . mutants. Anders Boyd, MPH, . PhD....
Switch to DRV/r + RAL
by debby-jeon
SPARE . Study. SPARE Study: switch to DRV/r + RAL...
ID Week Review 2015
by briana-ranney
Brian R. Wood, MD. Assistant Professor of Medicin...
P1084s: Impact of maternal
by olivia-moreira
tenofovir. . disoproxil. . fumarate. (TDF) . u...
Tyre Stewardship in Canada
by sherrill-nordquist
Presented to . New Zealand . Tyre. Industry Summ...
Florida AIDS Drug Assistance
by liane-varnes
Program. Improving Health. . . Promoting Wellness...
Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-
by min-jolicoeur
implementation of Dolutegravir. Meireles MV. , Pa...
Common Pharmacomistakes in Advanced Illness
by tawny-fly
Common Pharmacomistakes in Advanced Illness Opioi...
Joel E. Gallant, MD, MPH
by mastervisa
Medical Director, Specialty . Services. Southwest ...
Evolving Options for HBV Therapy:
by desiron
Navigating the New Treatment Landscape. Outline. I...
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Selecting an Initial Antiretroviral Therapy (ART) Regimen
by cappi
www.hivguidelines.org. Purpose of . This Guideline...
Target Date Funds and P
by unita
lan . S. ponsor Responsibilities. Marcia S. Wagner...
Renal and Bone Safety of
by ashley
Tenofovir. . Alafenamide. . vs. . Tenofovir. ....
Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E
by alyssa
302 Vol. 32, 2014, No. 3: 302–307Czech J. Fo...
Retirement Plan Consulting
by oconnor
Overview of Services. Table of Contents. About RPA...
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
by felicity
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112
by micah
Tenofovir. . Disoproxil. . Fumarate. to . Tenof...
Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial
by matthew167
NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...
COMING SOON:
by luanne-stotts
GENERIC ARVs. Tim Horn. Treatment Action Group. t...
TDF Microsoft Lync - Novembre 2010
by faustina-dinatale
Solutions & Architectures UC . Polycom. - Mi...
Switch to ATV/
by cheryl-pisano
r. + RAL. HARNESS Study. ATV/. r. 300/100 mg ....
COMPARATIVE INVESTIGATIONS ON NUTRITIONAL COMPOSITIONS OF O
by lois-ondreau
GROWN CEREALS AND THEIR RELATIONSHIPS. Dr. . Mirj...
Les satisfactions : traitements efficaces, robustes, avec u
by phoebe-click
Dr Denis Lacoste. Bordeaux. Les satisfactions : ....
ART Resistance and Second Line Regimens
by calandra-battersby
Learning Objectives. Understand when to switch to...
Adaptive non-inferiority
by cheryl-pisano
margins under observable non-constancy. Brett Han...
Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions
by pamella-moone
Guidelines for the Use of Antiretroviral Agents i...
Duke Energy Carolinas ATC Calculation Process
by stefany-barnette
ATC Training. December 15. th. , 2011. Agenda. Ob...
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
by conchita-marotz
A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...
Load More...
![Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)](https://thumbs.docslides.com/1058605/atazanavir-cobicistat-or-ritonavir-tdf-ftc-phase-2.jpg)
